Amyscan Healthcare develops ultra-sensitive diagnostic tests that detect and amplify trace amounts of disease-specific amyloid seeds in blood and other body fluids. Built on patented IIT Bombay technology, Amyscan is launching the world’s first blood test for accurate, affordable, and early detection of Parkinson’s disease. The scalable platform can be adapted for other major disorders, including Alzheimer’s disease, positioning Amyscan as a leader in next-generation molecular diagnostics.